It's all in the timing by Linda J. Bendall Blood

Slides:

Advertisements

Similar presentations

10.3 Workbook Corrections.

Advertisements

1 hr hr 8 hr 4-6 hr (M) Spindle-assembly checkpoint - confirms that all the chromosomes are properly attached to the spindles. Resting phase (G0)

A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies by Jutta Deckert, Peter U. Park,

Onion root tip and Whitefish

C e l l C y c l e. Cell Size Surface Area (length x width x 6) Volume (length x width x height) Ratio of Surface Area to Volume Ratio of Surface Area.

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target by Francis Mussai, Sharon Egan, Joseph Higginbotham-Jones,

An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity by Francesca S. Gazzaniga,

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Controlling a Cell’s Progress through the Cell Cycle

Why not the liver instead of the kidney?

Uncontrolled Wnt signaling causes leukemia

GVHD-associated immunodeficiency: soil or seed?

Do HSCs divide asymmetrically?

MBL: mostly benign lymphocytes, but…

Hydroxyurea makes inflammation “just right”?

Collaboration is required for successful immunotherapy

TCR-MHC-peptide(s): in vivo veritas

“Vitamin hypothesis”: explanation for allergy increase?

Dendritic cell homeostasis

Triple play of H pylori in ITP

Mitotic Exit Molecular Cell

Neonatal GATA1 mutant clones under the radar

Bulging glands? Blame it on B cells

Positioning NK-κB in multiple myeloma

Yin and yang of glucocorticoid receptors in apoptosis

When monocyte life hangs by a thread

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

BTK inhibition in myeloma: targeting the seed and the soil

BRAF inhibitor: targeted therapy in hairy cell leukemia

A cell by any other name by Narla Mohandas Blood

Transplants for the elderly in myeloma

by Thomas Rasmussen, Linda Jensen, Lone Honoré, and Hans Erik Johnsen

Mechanisms of HIV-associated lymphocyte apoptosis

T regulatory cells turn on T regulatory cells

Gnawing at Metchnikoff’s paradigm

CMV: when bad viruses turn good

by Corey S. Cutler, John Koreth, and Jerome Ritz

Functional neutrophils from human ES cells

Fluorescent neutrophils throw the spotlight on inflammation

Targeting kinases in CML CLL

Deep mining of the RBC proteome

The lazy leukocyte syndrome revisited

Has the T cell bitten off more than it can chew?

Basophils take a slice of IRF8 pie

P100: A Novel Proliferation-Associated Nuclear Protein Specifically Restricted to Cell Cycle Phases S, G2 , and M by H.J. Heidebrecht, F. Buck, J. Steinmann,

Blood Volume 92(10): November 15, 1998

Rare cells predict GVHD

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

HU for acute treatment of sickle VOC?

Gremlin: vexing VEGF receptor agonist

GATA2 finds its macrophage niche

A new red cell shape helps the clot

The ___ _____ has ____ main ______.

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Mitosis questions Aster Wars version…

3.2.5 Cell Cycle L.O: to state and describe the stages in the cell cycle to apply knowledge of the cell cycle to cancer treatment.

Volume 143, Issue 6, (December 2010)

Mitotic Inhibitors Journal of Thoracic Oncology

by Christine L. Kempton, and Amanda B. Payne

John Koreth, Edwin P. Alyea, William J. Murphy, Lisbeth A. Welniak

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Schematic model of the mechanism of Tak1 protection of HSPC survival.

Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor Ibrutinib in Patients with Hairy Cell Leukemia: Stage 1 Results of a Phase 2 Study by Jeffrey.

Anti-CD20-IL-21 fusokine: the tail wags the dog

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Pure red cell aplasia by Robert T. Means Blood

Presentation transcript:

It's all in the timing by Linda J. Bendall Blood Volume 118(23):5983-5984 December 1, 2011 ©2011 by American Society of Hematology

Vincristine (Vin) triggers apoptosis subsequent to disruption of the mitotic spindle during mitosis. Vincristine (Vin) triggers apoptosis subsequent to disruption of the mitotic spindle during mitosis. Doxorubicin (doxo) activates p53, resulting in a cell cycle arrest in the G2 phase. This prevents cells entering mitosis, thereby avoiding the cytotoxic effects of vincristine. Professional illustration by Debra T. Dartez. Linda J. Bendall Blood 2011;118:5983-5984 ©2011 by American Society of Hematology